KELLY DARDEN: Open Payments
NPI 1629342951 · GRAHAM, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 20 payments from 12 companies in 2025. Trend: 2023 $2,822 · 2024 $2,000 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $32 |
| Lundbeck LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Abbott Laboratories | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Wegovy, Ozempic, JARDIANCE, MOUNJARO, VYEPTI, Kerendia, LEQVIO, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
